通用型富血小板血浆制备方法的研究

王璐 ,  吴琼 ,  姚新月 ,  毛平平 ,  杨奕 ,  罗开云 ,  李娜 ,  王淑君

中国输血杂志 ›› 2026, Vol. 39 ›› Issue (7) : 840 -845.

PDF (2428KB)
中国输血杂志 ›› 2026, Vol. 39 ›› Issue (7) : 840 -845. DOI: 10.13303/j.cjbt.issn.1004-549x.2026.07.004
论著

通用型富血小板血浆制备方法的研究

作者信息 +

Study on preparation of universal platelet-rich plasma

Author information +
文章历史 +
PDF (2485K)

摘要

目的 为平战时大批量或紧急情况下救治伤患赢得时间,消除血型匹配要求,促进富血小板血浆(PRP)实现产品化,探讨通用型 PRP 的混合配置比例。方法 将 O、A、B、AB 不同血型的 PRP 混合,根据混合后的 PRP 中抗-A 与抗-B 效价强度变化趋势确定最佳比例。 通过 ELISA 法测定混合前和混合后 PRP 中生长因子 PDGF-AA、PDGF-BB、EGF、TGF-β1 和 VEGF 含量。结果 A ∶B ∶AB 体积比例为6 ∶2. 5 ∶24 时,混合 PRP 在微柱凝胶抗人球蛋白卡中与 A 细胞和 B 细胞的反应强度均为阴性,即为通用型 PRP,其生长因子含量未降低。结论 有望通过抗原抗体反应中和血型抗体,实现通用型 PRP 制备。

Abstract

Objective To improve the efficiency of patient treatment in routine, emergency, and mass casualty scenarios (both peacetime and wartime), eliminate reliance on blood type compatibility, and promote the productization of platelet-rich plasma (PRP), this study investigated the optimal mixing ratio for developing a universal PRP formulation. Methods PRP was prepared from donors with blood types O, A, B, and AB. Samples were mixed in varying proportions, and the optimal ratio was determined based on the trend of anti-A and anti-B antibody titers in the mixed PRP. Concentrations of the growth factors PDGF-AA, PDGF-BB, EGF, TGF-β1, and VEGF were measured by enzyme-linked immunosorbent assay (ELISA) before and after mixing. Results A mixing ratio of A ∶B ∶AB = 6 ∶2. 5 ∶24 resulted in no detectable agglutination with either A or B cells in the microcolumn gel system, indicating the absence of immunological reactivity and confirming universal compatibility. Importantly, the levels of all measured growth factors remained unchanged following mixing, suggesting preservation of biological activity. Conclusion These findings suggest that universal PRP can be prepared by neutralizing blood type antibodies through antigen-antibody reactions.

关键词

富血小板血浆 / 血型抗体效价 / 微柱凝胶抗人球蛋白试验 / 生长因子

Key words

platelet-rich plasma / titer of blood group antibodies / microcolumn gel anti-human globulin test / growth factor

引用本文

引用格式 ▾
王璐,吴琼,姚新月,毛平平,杨奕,罗开云,李娜,王淑君. 通用型富血小板血浆制备方法的研究[J]. 中国输血杂志, 2026, 39(7): 840-845 DOI:10.13303/j.cjbt.issn.1004-549x.2026.07.004

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

王淑君,李兆杰,杨奕,等. 血小板衍生制品促进创面愈合的研究进展[J].临床输血与检验,2024, 26(6):825-834.

[2]

WANG S J, LI Z J, YANG Y, et al. Platelet-derived products in wound healing[J].J Cli Transfus Lab Med, 2024, 26(6):825-834.

[3]

WANG S J, DING W W, DU Y, et al. Allogeneic platelet gel therapy for refractory abdominal wound healing:a preliminary study[J].Adv Clin Exp Med, 2023, 32(8):865-872.

[4]

LI S Z, YANG G, CHEN R J, et al. Use of adjunctive platelet-rich plasma for healing during arthroscopic release and repair for recalcitrant lateral epicondylitis: a prospective, double-blind, randomized controlled trial[J].Am J Sports Med, 2025, 53(8):1817-1825.

[5]

HASSAN N H, AHMAD R E, KAMARUL T, et al. Allogenic platelet-rich plasma for treating cartilage injury:a systematic review of the evidence on the basic sciences for potential future applications[J].Cells Tissues Organs, 2024, 213(4):338-355.

[6]

ARORA V, JOSHI A, ANTHWAL N, et al. Bone regeneration using PRF, PRP and β-TCP in bone defects[J].Bioinformation, 2025, 21(4):793-796.

[7]

LI Z, ZHOU Y, WANG S J, et al. Nasointestinal tube feeding of platelet-rich plasma cured obscure gastrointestinal bleeding[J].Chin Med J (Engl), 2022, 135(19):2383-2385.

[8]

LIU L, YANG D, DUAN B L, et al. Effectiveness and safety of platelet-rich plasma combined with pulsed radiofrequency to treat patients with infraorbital neuralgia:a propensity score-matched analysis of a multi-center, prospective cohort protocol[J].J Pain Res, 2025, 18:1643-1656.

[9]

穆士杰,赵树铭,王文婷. 自体单采富血小板血浆治疗薄型子宫内膜的专家共识[J].临床输血与检验, 2023, 25(3):289-296.

[10]

MU S J, ZHAO S M, WANG W T. Expert consensus on autologous apheresis platelet-rich plasma in the treatment of thin endometrium[J].J Cli Transfus Lab Med, 2023, 25(3):289-296.

[11]

FRAIDAKIS M, GIANNAKAKIS G, ANIFANTAKI A, et al. Intraovarian platelet-rich plasma Injections:safety and thoughts on efficacy based on a single centre experience with 469 women[J].Cureus, 2023, 15 (5):e38674.

[12]

XIAO C, ZHANG G H, LI H Q, et al. Meta-analysis of efficacy of platelet-rich plasma combined with minoxidil for androgenetic alopecia[J]. Aesthetic Plast Surg, 2024, 48(21):4554-4566.

[13]

单桂秋,施琳颖,李艳辉,等. 自体富血小板血浆制备技术专家共识[J].中国输血杂志, 2021, 34(7):677-683.

[14]

SHAN G Q, SHI L Y, LI Y H, et al. Expert consensus on preparation technique of autologous platelet-rich plasma[J].Chin J Blood Transfusion, 2021, 34(7):677-683.

[15]

王淑英. 通用型病毒灭活血浆制备方法研究[D]. 中国人民解放军医学院,2012.

[16]

WANG S Y. Study on preparation of virus-inactivated universal plasma[D]. Chinese PLA Medical School, 2012.

[17]

李少文,朱展鸿,余楠,等. 富血小板血浆制备及其质量评价体系初探[J].中国输血杂志, 2022, 35(10):1085-1091.

[18]

LI S W, ZHU Z H, YU N, et al. Review on platelet-rich plasma preparation and its quality evaluation[J].Chin J Blood Transfusion, 2022, 35(10):1085-1091.

[19]

尚红,王毓三,申子瑜. 全国临床检验操作规程[M]. 人民卫生出版社:201911:2335.

[20]

SHANG H, WANG Y S, SHEN Z Y. National operating procedures for clinical laboratory tests[M]. People′ s Medical Publishing House:201911:2335.

[21]

陈冠伊. 通用型血浆体内外免疫安全性研究[D].中国人民解放军医学院, 2017.

[22]

CHEN G Y. Study on the immune safety of universal plasma in vivo and in vitro[D].Medical School PLA, 2017.

[23]

肖瑞卿,隆晓秋,王泽蓉,等. 血浆与红细胞悬液上清液中抗体效价及血浆蛋白的含量分析[J].中国输血杂志, 2011, 24(11):929-930.

[24]

XIAO R Q, LONG X Q, WANG Z R, et al. Analysis of antibody titer and plasma protein content in plasma and supernatant of red blood cell suspension[J].Chin J Blood Transfusion, 2011, 24(11):929-930.

[25]

赵敏. 血浆与红细胞悬液上清液中抗体效价及血浆蛋白的含量研究[J].中国医疗前沿, 2012, 7(24):53-54.

[26]

ZHAO M. Content research on antibody titer and plasma protein of plasma and red blood cell suspension supernatant fluid[J].National Medical Frontiers of China, 2012, 7(24):53-54.

[27]

杨梦娇,周利,曹兴明,等. 正常 O 型人血清 ABO 血型抗体主要类别的分析[J].中国实验诊断学, 2013, 17(4):697-699.

[28]

YANG M J, ZHOU L, CAO X M, et al. Analysis of the major ABO blood group antibody class in type O human serum[J].Chin J Lab Diagn, 2013, 17(4):697-699.

[29]

CHEN G Y, ZHU L G, WANG S F, et al. Study on the immunological safety of universal plasma in the Chinese population in vitro[J].Transfus Apher Sci, 2017, 56(2):171-174.

[30]

齐清,李兆杰,吴琼,等. 储存条件对长期保存 PRP 生长因子的影响[J].中国输血杂志, 2025, 386):759-765.

[31]

QI Q, LI Z J, WU Q, et al. Effect of storage conditions on long-term preservation of PRP growth factors[J].Chin J Blood Transfusion, 2025, 386):759-765.

基金资助

东部战区总医院院内课题(22LCZLXJS52)

AI Summary AI Mindmap
PDF (2428KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉